Lewy Body Dementia (LBD) is a brain disease that’s often misunderstood. It’s actually the second most common type of ...

Share on Pinterest A new drug candidate called SAK3 successfully stopped the progression of a form of dementia in mice. Jacek Kadaj/Getty Images A drug candidate called SAK3 prevented further loss of ...

Lewy body dementia (LBD) is a type of progressive disease that has affected more than a million Americans, according to the Lewy Body Dementia Association. Over time, it destroys brain cells and can ...

(RTTNews) - CervoMed Inc. (CRVO) has announced positive 32-week data from the Extension phase of its phase IIb RewinD-LB trial of oral investigational drug Neflamapimod for the treatment of dementia ...

Lewy body dementia is a progressive neurodegenerative disorder brought on by an excess of the protein alpha-synuclein in the brain. These deposits, known as Lewy bodies, can inhibit the production of ...

Results from a new study reinforce the notion that dementia with Lewy bodies can be pathologically classified into two different disease types. Results obtained in a study recently completed at the ...

Q: I have heard that Parkinson’s disease and Lewy body dementia are related. What exactly is Lewy body dementia? A: Lewy Body Dementia (LBD) is a brain disease that's cause is unknown. Protein ...

(WNDU) - We all know about Alzheimer’s disease, in fact, many of us know someone who has been impacted by it. But there is another form of dementia that affects more than a million Americans. And yet, ...

What is Lewy body dementia? Dr. Frederich H. Lewy, a German neurologist working alongside Dr. Alois Alzheimer, first discovered the hallmark brain abnormalities in the 1900s. Alpha-synuclein protein, ...

While Alzheimer’s disease is the most common type of dementia, there’s another variation that is also relatively prevalent. Lewy body dementia (LBD) affects more than 1 million people in the US. It is ...

The FDA granted breakthrough device designation to Amprion for its SYNTap Test, which detects a distinct protein as an indicator of Alzheimer’s disease with Lewy bodies, according to a news release.